Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
Add more filters











Publication year range
1.
Acta Cir Bras ; 35(3): e202000303, 2020.
Article in English | MEDLINE | ID: mdl-32490900

ABSTRACT

PURPOSE: To evaluate the in vivo response of photobiomodulation therapy associated with norbixin-based poly(hydroxybutyrate) membrane (PHB) in tenotomized calcaneal tendon. METHODS: Thirty rats were randomly allocated to six groups (n=5 each): LED groups (L1, L2 and L3) and membrane + LED groups (ML1, ML2 and ML3). The right calcaneal tendons of all animals were sectioned transversely and were irradiated with LED daily, one hour after surgery every 24 hours, until the day of euthanasia. At the end of the experiments the tendons were removed for histological analysis. RESULTS: The histological analysis showed a significant reduction in inflammatory cells in the ML1, ML2 and ML3 groups (p=0.0056, p=0.0018 and p<0.0001, respectively) compared to those in the LED group. There was greater proliferation of fibroblasts in the ML1 (p<0.0001) and L3 (p<0.0001) groups. A higher concentration of type I collagen was also observed in the ML1 group (p=0.0043) replacing type III collagen. CONCLUSION: Photobiomodulation in association with norbixin-based PHB membrane led to control of the inflammatory process. However, it did not favor fibroblast proliferation and did not optimize type I collagen formation in the expected stage of the repair process.


Subject(s)
Achilles Tendon/radiation effects , Carotenoids/pharmacology , Hydroxybutyrates/pharmacology , Low-Level Light Therapy/methods , Tendinopathy/radiotherapy , Tenotomy/methods , Achilles Tendon/drug effects , Achilles Tendon/surgery , Animals , Collagen/pharmacology , Collagen Type I/analysis , Collagen Type I/drug effects , Collagen Type III/analysis , Collagen Type III/drug effects , Drug Evaluation, Preclinical , Fibroblasts/chemistry , Fibroblasts/drug effects , Male , Prohibitins , Random Allocation , Rats , Rats, Wistar , Wound Healing/drug effects , Wound Healing/radiation effects
2.
Acta Cir Bras ; 34(11): e201901101, 2020.
Article in English | MEDLINE | ID: mdl-31939594

ABSTRACT

PURPOSE: To determine the efficacy of norbixin-based poly(hydroxybutyrate) (PHB) membranes for Achilles tendon repair. METHODS: Thirty rats were submitted to total tenotomy surgery of the right Achilles tendon and divided into two groups (control and membrane; n = 15 each), which were further subdivided into three subgroups (days 7, 14, and 21; n = 5 each). Samples were analyzed histologically. RESULTS: Histological analysis showed a significant reduction in inflammatory infiltrates on days 7, 14 (p < 0.0001 for both), and 21 (p = 0.0004) in the membrane group compared to that in the control group. There was also a significant decrease in the number of fibroblasts in the control group on days 7, 14 (p < 0.0001), and 21 (p = 0.0032). Further, an increase in type I collagen deposition was observed in the membrane group compared to that in the control group on days 7 (p = 0.0133) and 14 (p = 0.0107). CONCLUSION: Treatment with norbixin-based PHB membranes reduces the inflammatory response, increases fibroblast proliferation, and improves collagen production in the tendon repair region, especially between days 7 and 14.


Subject(s)
Achilles Tendon/drug effects , Achilles Tendon/surgery , Carotenoids/pharmacology , Hydroxybutyrates/pharmacology , Polyesters/pharmacology , Tenotomy/methods , Achilles Tendon/pathology , Animals , Collagen Type I/analysis , Collagen Type I/drug effects , Collagen Type III/analysis , Collagen Type III/drug effects , Fibroblasts/drug effects , Humans , Male , Prohibitins , Rats, Wistar , Reference Values , Regeneration/drug effects , Reproducibility of Results , Time Factors , Treatment Outcome
3.
Acta cir. bras ; Acta cir. bras;35(3): e202000303, 2020. tab, graf
Article in English | LILACS | ID: biblio-1130621

ABSTRACT

Abstract Purpose: To evaluate the in vivo response of photobiomodulation therapy associated with norbixin-based poly(hydroxybutyrate) membrane (PHB) in tenotomized calcaneal tendon. Methods: Thirty rats were randomly allocated to six groups (n=5 each): LED groups (L1, L2 and L3) and membrane + LED groups (ML1, ML2 and ML3). The right calcaneal tendons of all animals were sectioned transversely and were irradiated with LED daily, one hour after surgery every 24 hours, until the day of euthanasia. At the end of the experiments the tendons were removed for histological analysis. Results: The histological analysis showed a significant reduction in inflammatory cells in the ML1, ML2 and ML3 groups (p=0.0056, p=0.0018 and p<0.0001, respectively) compared to those in the LED group. There was greater proliferation of fibroblasts in the ML1 (p<0.0001) and L3 (p<0.0001) groups. A higher concentration of type I collagen was also observed in the ML1 group (p=0.0043) replacing type III collagen. Conclusion: Photobiomodulation in association with norbixin-based PHB membrane led to control of the inflammatory process. However, it did not favor fibroblast proliferation and did not optimize type I collagen formation in the expected stage of the repair process.


Subject(s)
Animals , Male , Rats , Achilles Tendon/radiation effects , Carotenoids/pharmacology , Low-Level Light Therapy/methods , Tendinopathy/radiotherapy , Tenotomy/methods , Hydroxybutyrates/pharmacology , Achilles Tendon/surgery , Achilles Tendon/drug effects , Wound Healing/drug effects , Wound Healing/radiation effects , Random Allocation , Collagen/pharmacology , Rats, Wistar , Collagen Type I/analysis , Collagen Type I/drug effects , Collagen Type III/analysis , Collagen Type III/drug effects , Drug Evaluation, Preclinical , Fibroblasts/drug effects , Fibroblasts/chemistry , Prohibitins
4.
Acta cir. bras ; Acta cir. bras;34(11): e201901101, Nov. 2019. tab, graf
Article in English | LILACS | ID: biblio-1054681

ABSTRACT

Abstract Purpose: To determine the efficacy of norbixin-based poly(hydroxybutyrate) (PHB) membranes for Achilles tendon repair. Methods: Thirty rats were submitted to total tenotomy surgery of the right Achilles tendon and divided into two groups (control and membrane; n = 15 each), which were further subdivided into three subgroups (days 7, 14, and 21; n = 5 each). Samples were analyzed histologically. Results: Histological analysis showed a significant reduction in inflammatory infiltrates on days 7, 14 (p < 0.0001 for both), and 21 (p = 0.0004) in the membrane group compared to that in the control group. There was also a significant decrease in the number of fibroblasts in the control group on days 7, 14 (p < 0.0001), and 21 (p = 0.0032). Further, an increase in type I collagen deposition was observed in the membrane group compared to that in the control group on days 7 (p = 0.0133) and 14 (p = 0.0107). Conclusion: Treatment with norbixin-based PHB membranes reduces the inflammatory response, increases fibroblast proliferation, and improves collagen production in the tendon repair region, especially between days 7 and 14.


Subject(s)
Humans , Animals , Male , Polyesters/pharmacology , Achilles Tendon/surgery , Achilles Tendon/drug effects , Carotenoids/pharmacology , Tenotomy/methods , Hydroxybutyrates/pharmacology , Reference Values , Regeneration/drug effects , Achilles Tendon/pathology , Reproducibility of Results , Rats, Wistar , Collagen Type I/analysis , Collagen Type I/drug effects , Collagen Type III/analysis , Collagen Type III/drug effects , Fibroblasts/drug effects
5.
J Tissue Viability ; 26(2): 131-137, 2017 May.
Article in English | MEDLINE | ID: mdl-28162862

ABSTRACT

It has been reported that carbohydrates confer physicochemical properties to the wound environment that improves tissue repair. We evaluated in vitro and in vivo wound healing during maltodextrin/ascorbic acid treatment. In a fibroblast monolayer scratch assay, we demonstrated that maltodextrin/ascorbic acid stimulated monolayer repair by increasing collagen turnover coordinately with TGF-ß1 expression (rising TGF-ß1 and MMP-1 expression, as well as gelatinase activity, while TIMP-1 was diminished), similar to in vivo trends. On the other hand, we observed that venous leg ulcers treated with maltodextrin/ascorbic acid diminished microorganism population and improved wound repair during a 12 week period. When maltodextrin/ascorbic acid treatment was compared with zinc oxide, almost four fold wound closure was evidenced. Tissue architecture and granulation were improved after the carbohydrate treatment also, since patients that received maltodextrin/ascorbic acid showed lower type I collagen fiber levels and increased extracellular alkaline phosphatase activity and blood vessels than those treated with zinc oxide. We hypothesize that maltodextrin/ascorbic acid treatment stimulated tissue repair of chronic wounds by changing the stage of inflammation and modifying collagen turnover directly through fibroblast response.


Subject(s)
Antioxidants/administration & dosage , Ascorbic Acid/administration & dosage , Polysaccharides/administration & dosage , Varicose Ulcer/drug therapy , Wound Healing/drug effects , Administration, Cutaneous , Adult , Aged , Aged, 80 and over , Case-Control Studies , Collagen Type III/drug effects , Drug Combinations , Female , Humans , Longitudinal Studies , Lower Extremity , Male , Middle Aged , Pilot Projects , Prospective Studies , Random Allocation , Tissue Inhibitor of Metalloproteinase-1/drug effects , Transforming Growth Factor beta1/drug effects , Varicose Ulcer/microbiology , Varicose Ulcer/pathology , Zinc Oxide/administration & dosage
6.
Pesqui. vet. bras ; Pesqui. vet. bras;36(12): 1221-1226, Dec. 2016. tab, ilus
Article in English | LILACS, VETINDEX | ID: biblio-842029

ABSTRACT

Collagen plays essential roles in remodeling uterine tissue during decidualization, implantation, pregnancy and involution. To understand whether the progestational agent medroxyprogesterone acetate (MPA) can modify the organization and deposit of collagen in the uteri of normal bitches (Canis Tlupus familiaris), we assessed uterine tissues by histochemistry. Uteri were grouped as: nulliparous (n=11), multiparous (n=11) and treated with MPA (n=11; nulliparous with two treatments; 5mg/kg; i.m.). The amount, location and birefringence of interstitial collagen types I and III in the fold and base of the endometrial stroma and the myometrial muscular layers were studied on sections stained with Picrosirius Red by polarized light microscopy and evaluated by ANOVA. No differences were observed in the endometrium. In the myometrium, differences were observed in collagen type I between MPA-treated and nulliparous uteri vs. multiparous (p<0.05), and differences in collagen type III between nulliparous and multiparous uteri vs. MPA-treated (p=0.0001). In conclusion, two doses of MPA had no significant effect on the investigated collagens in the extracellular matrix.(AU)


Subject(s)
Animals , Female , Dogs , Collagen Type III/drug effects , Collagen Type I/drug effects , Medroxyprogesterone Acetate/adverse effects , Uterus/anatomy & histology , Contraceptive Agents/analysis , Fibrillar Collagens
7.
Acta Cir Bras ; 30(1): 24-33, 2015 Jan.
Article in English | MEDLINE | ID: mdl-25627268

ABSTRACT

PURPOSE: To evaluate the effect of propranolol on capsular architecture around silicone implants by measuring the inflammation, capsular thickness, and collagen fiber density, using a guinea pig experimental model. METHODS: Thirty six adult male guinea pigs randomly divided into two groups (n=18) were used. Each one received a silicone implant with textured-surface. The capsular tissue around implants from untreated or treated animals with the beta-adrenoceptor antagonist propranolol (10 mg/kg, dissolved in daily water) were analyzed for inflammation by histological scoring, capsular thickness by computerized histometry, and collagen fibers type I and Type III density by picrosirius polarization at different time points (7, 14 or 21 days after silicone implantation). RESULTS: Propranolol treatment reduced inflammation and impaired capsular thickness and delayed collagen maturation around the textured implant. CONCLUSION: Propranolol reduces the risk of developing capsular contracture around silicone implants with textured surface.


Subject(s)
Adrenergic beta-Antagonists/pharmacology , Implant Capsular Contracture/prevention & control , Propranolol/pharmacology , Silicone Gels/adverse effects , Adrenergic beta-Antagonists/therapeutic use , Animals , Breast Implants/adverse effects , Collagen Type I/analysis , Collagen Type I/drug effects , Collagen Type III/analysis , Collagen Type III/drug effects , Disease Models, Animal , Guinea Pigs , Humans , Implant Capsular Contracture/pathology , Implants, Experimental/adverse effects , Male , Propranolol/therapeutic use , Random Allocation , Reproducibility of Results , Subcutaneous Tissue/drug effects , Subcutaneous Tissue/pathology , Time Factors , Treatment Outcome
8.
Acta cir. bras ; Acta cir. bras;30(1): 24-33, 01/2015. tab, graf
Article in English | LILACS | ID: lil-735711

ABSTRACT

PURPOSE: To evaluate the effect of propranolol on capsular architecture around silicone implants by measuring the inflammation, capsular thickness, and collagen fiber density, using a guinea pig experimental model. METHODS: Thirty six adult male guinea pigs randomly divided into two groups (n=18) were used. Each one received a silicone implant with textured-surface. The capsular tissue around implants from untreated or treated animals with the beta-adrenoceptor antagonist propranolol (10 mg/kg, dissolved in daily water) were analyzed for inflammation by histological scoring, capsular thickness by computerized histometry, and collagen fibers type I and Type III density by picrosirius polarization at different time points (7, 14 or 21 days after silicone implantation). RESULTS: Propranolol treatment reduced inflammation and impaired capsular thickness and delayed collagen maturation around the textured implant. CONCLUSION: Propranolol reduces the risk of developing capsular contracture around silicone implants with textured surface. .


Subject(s)
Animals , Guinea Pigs , Humans , Male , Adrenergic beta-Antagonists/pharmacology , Implant Capsular Contracture/prevention & control , Propranolol/pharmacology , Silicone Gels/adverse effects , Adrenergic beta-Antagonists/therapeutic use , Breast Implants/adverse effects , Collagen Type I/analysis , Collagen Type I/drug effects , Collagen Type III/analysis , Collagen Type III/drug effects , Disease Models, Animal , Implant Capsular Contracture/pathology , Implants, Experimental/adverse effects , Propranolol/therapeutic use , Random Allocation , Reproducibility of Results , Subcutaneous Tissue/drug effects , Subcutaneous Tissue/pathology , Time Factors , Treatment Outcome
9.
Int Braz J Urol ; 40(2): 257-63, 2014.
Article in English | MEDLINE | ID: mdl-24856494

ABSTRACT

PURPOSE: To evaluate the synthesis of type I (mature) and type III (immature) collagen in bladder suture of rats treated with a combination of tacrolimus and mycophenolate mofetil for 15 days. MATERIALS AND METHODS: Thirty rats were divided into 3 groups: the sham, control and experimental groups. All the animals underwent laparotomy, cystotomy and bladder suture in two planes with surgical PDS 5-0 thread. The sham group did not receive treatment. The control group received saline solution, and the experimental group received 0.1mg/kg/day of tacrolimus with 20mg/kg/day of mycophenolate mofetil, for 15 days. From then on, the tacrolimus was dosed. The surgical specimens of the bladder suture area were processed so that the total type I and type III collagen could be measured by the picrosirius red technique. RESULTS: There was a predominance of type I collagen production in the sham and control groups compared to the experimental group, in which type III collagen was predominant. The production of total collagen did not change. CONCLUSION: The association of tacrolimus and mycophenolate mofetil in animals qualitatively changes the production of collagen after 15 days with a predominance of type III collagen.


Subject(s)
Collagen Type III/biosynthesis , Collagen Type I/biosynthesis , Immunosuppressive Agents/therapeutic use , Mycophenolic Acid/analogs & derivatives , Sutures , Tacrolimus/therapeutic use , Urinary Bladder/surgery , Animals , Collagen Type I/drug effects , Collagen Type III/drug effects , Mycophenolic Acid/therapeutic use , Rats, Wistar , Reproducibility of Results , Suture Techniques , Treatment Outcome , Wound Healing/drug effects
10.
Int. braz. j. urol ; 40(2): 257-265, Mar-Apr/2014. graf
Article in English | LILACS | ID: lil-711695

ABSTRACT

PurposeTo evaluate the synthesis of type I (mature) and type III (immature) collagen in bladder suture of rats treated with a combination of tacrolimus and mycophenolate mofetil for 15 days.Materials and MethodsThirty rats were divided into 3 groups: the sham, control and experimental groups. All the animals underwent laparotomy, cystotomy and bladder suture in two planes with surgical PDS 5-0 thread. The sham group did not receive treatment. The control group received saline solution, and the experimental group received 0.1mg/kg/day of tacrolimus with 20mg/kg/day of mycophenolate mofetil, for 15 days. From then on, the tacrolimus was dosed. The surgical specimens of the bladder suture area were processed so that the total type I and type III collagen could be measured by the picrosirius red technique.ResultsThere was a predominance of type I collagen production in the sham and control groups compared to the experimental group, in which type III collagen was predominant. The production of total collagen did not change.ConclusionThe association of tacrolimus and mycophenolate mofetil in animals qualitatively changes the production of collagen after 15 days with a predominance of type III collagen.


Subject(s)
Animals , Collagen Type I/biosynthesis , Collagen Type III/biosynthesis , Immunosuppressive Agents/therapeutic use , Mycophenolic Acid/analogs & derivatives , Sutures , Tacrolimus/therapeutic use , Urinary Bladder/surgery , Collagen Type I/drug effects , Collagen Type III/drug effects , Mycophenolic Acid/therapeutic use , Rats, Wistar , Reproducibility of Results , Suture Techniques , Treatment Outcome , Wound Healing/drug effects
11.
Arch Oral Biol ; 58(6): 646-56, 2013 Jun.
Article in English | MEDLINE | ID: mdl-23290003

ABSTRACT

OBJECTIVE: In this work we evaluated the bone-forming potential of BMP4, TGFß1 and BMP4/TGFß1 mixed by performing histological and morphometric analysis. We also evaluated the immunolabelling of fibronectin (FN) and collagen type III (Col III), two determinant proteins for the early phase of bone repair. DESIGN: Histological, histomorphometric and immunohistochemistry analysis were used to evaluate new bone and blood vessels formation as well as fibronectin and collagen type III expression. 112 male Wistar rats weighing 250-300g had their maxillary second molar extracted. Sockets filled with blood clot (BC) or treated with L (empty liposome), P (PBS), BP (BMP-4 in PBS) and TP (TGF-ß1 in PBS), as well as with BL (BMP-4 in liposome) and TL (TGF-ß1 in liposome) administered isolated or in association (BTL) were obtained. The animals were sacrificed at 3, 7, 14 and 21 days after surgery. RESULTS: An increased percentage of bone trabeculae, and a higher number of blood vessels were observed in groups BL or TL administered isolated or in association when compared to groups BC, L, P, BP and TP. Fibronectin and collagen type III analysis revealed enhanced expression firstly detected at 3 days followed by a peak at 7 days. Lower levels of immunoreactivity were observed in the sockets filled with blood clot, and treated with L, P, BP and TP when compared with sockets from groups BL, TL and BTL. CONCLUSION: The present study indicates growth factors carried by liposomes, either in isolated or associated forms, as successful enhancers of the healing process in rat tooth sockets. We also conclude that the expression of fibronectin and collagen type III increases during the early phases of bone repair.


Subject(s)
Alveolar Process/drug effects , Bone Morphogenetic Protein 4/administration & dosage , Osteogenesis/drug effects , Transforming Growth Factor beta1/administration & dosage , Alveolar Process/blood supply , Alveolar Process/pathology , Animals , Blood Coagulation/physiology , Bone Morphogenetic Protein 4/pharmacology , Collagen Type III/drug effects , Drug Carriers , Fibronectins/drug effects , Liposomes , Male , Maxilla/blood supply , Maxilla/drug effects , Maxilla/pathology , Maxilla/surgery , Neovascularization, Physiologic/drug effects , Osteoblasts/drug effects , Osteoblasts/pathology , Osteoclasts/drug effects , Osteoclasts/pathology , Random Allocation , Rats , Rats, Wistar , Time Factors , Tooth Extraction , Tooth Socket/blood supply , Tooth Socket/drug effects , Tooth Socket/pathology , Tooth Socket/surgery , Transforming Growth Factor beta1/pharmacology , Wound Healing/drug effects
12.
Respir Physiol Neurobiol ; 162(2): 126-31, 2008 Jul 31.
Article in English | MEDLINE | ID: mdl-18586579

ABSTRACT

We studied the results of chronic oral administration of amiodarone on in vitro lung tissue mechanics, light and electron microscopy. Fifteen Wistar male rats were divided into three groups. In control (CTRL) group animals received saline (0.5 mL/day). In amiodarone (AMIO) groups, amiodarone was administered by gavage at a dose of 175 mg/kg 5 days per week for 6 (6AMIO) or 12 weeks (12AMIO). Lung tissue strips were analyzed 24h after the last drug administration. Tissue resistance and elastance were higher in 6AMIO and 12AMIO than in CTRL, while hysteresivity was similar in all groups. Total amount of collagen fibers in lung parenchyma increased progressively with the time course of the lesion. However, at 6 weeks there was an increase in the amount of type III collagen fibers, while in 12AMIO mainly type I collagen fibers were found. In our study amiodarone increased lung tissue impedance that was accompanied by matrix remodeling and lesion of type II pneumocytes.


Subject(s)
Amiodarone/adverse effects , Anti-Arrhythmia Agents/adverse effects , Extracellular Matrix/drug effects , Lung/drug effects , Respiratory Mechanics/drug effects , Analysis of Variance , Animals , Collagen Type I/drug effects , Collagen Type III/drug effects , Dose-Response Relationship, Drug , Drug Administration Schedule , Elasticity/drug effects , In Vitro Techniques , Lung/ultrastructure , Male , Rats , Rats, Wistar , Statistics, Nonparametric , Time Factors
13.
Cytokine ; 39(2): 130-7, 2007 Aug.
Article in English | MEDLINE | ID: mdl-17728137

ABSTRACT

This study evaluated the effects of bFGF and TGF-beta, individually and combined, on cell proliferation and collagen metabolism. Primary human periodontal ligament cells were stimulated with two concentrations (1 and 10 ng/ml) of each growth factor, both individually and combined. Proliferation was determined by a commercial biochemical assay. Real time RT-PCR determined gene expression of MMP-1 and -2, collagen types I and III, TIMP-1, -2 and -3. Autocrine effects on synthesis of bFGF and TGF-beta were evaluated by ELISA. Only TGF-beta, either isolated or associated with bFGF, significantly increased cell proliferation. TGF-beta had anabolic effects, increasing expression of type I and III collagen as well as of TIMPs, whereas bFGF had opposite effects. When bFGF and TGF-beta were associated, the anabolic effects prevailed. Synthesis of TGF-beta was induced only by the association of lower concentrations of the growth factors, whereas there was a dose-dependent production of bFGF. It is concluded that bFGF had a predominantly catabolic effect, and TGF-beta exerted an anabolic effect on hPDL cells.


Subject(s)
Collagen Type III/metabolism , Collagen Type I/metabolism , Fibroblast Growth Factor 2/physiology , Fibroblasts/metabolism , Periodontal Ligament/metabolism , Transforming Growth Factor beta/physiology , Cell Line , Cell Proliferation , Collagen Type I/drug effects , Collagen Type III/drug effects , Fibroblast Growth Factor 2/pharmacology , Humans , Matrix Metalloproteinase 1/metabolism , Matrix Metalloproteinase 2/metabolism , Periodontal Ligament/cytology , Tissue Inhibitor of Metalloproteinases/metabolism , Transforming Growth Factor beta/pharmacology
14.
Am J Hypertens ; 17(6): 516-22, 2004 Jun.
Article in English | MEDLINE | ID: mdl-15177525

ABSTRACT

Male erectile dysfunction is increased in prevalence in patients with hypertension. Previous experiments from our group demonstrated morphologic changes in erectile tissue from male spontaneously hypertensive rats (SHR). The aim of the present study was to determine whether blood pressure (BP) control is enough to preserve cavernous tissue from the deleterious effect of arterial hypertension. Eight-week-old male SHR and normotensive Wistar-Kyoto rats (WKY) were studied during 6 months: Group 1 (n = 10) SHR; group 2 (n = 10) SHR with 7.5 mg/kg/d candesartan (C); group 3 (n = 10) SHR with 100 mg/kg/d atenolol (AT); and group 4 (n = 10) WKY. At the end of the experiment all the animals were killed for microscopic studies. Cavernous tissue was processed by hematoxylin-eosin, Masson's trichrome, monoclonal anti-alpha-smooth muscle actin, and anticollagen type III. Cavernous smooth muscle (CSM) and vascular smooth muscle (VSM) from cavernous arteries and the amounts of collagen type III were evaluated. At the end of the experiment, SHR with C and AT showed similar control in BP (group 2: 131.3 +/- 5.5 mm Hg; group 3: 136.5 +/- 2.9 mm Hg) compared with untreated SHR (group 1: 199.6 +/- 5.1 mm Hg). However, animals with C presented significantly lower values (P <.01) of CSM layer in cavernous space and VSM in cavernous arteries (P <.01), and lower amounts of collagen type III (P <.01) compared to SHR with AT and untreated SHR. We conclude that C provides a significant protective role against structural changes in vessels as well as in cavernous spaces of the erectile tissue, caused by arterial hypertension in SHR, beyond BP control.


Subject(s)
Blood Pressure/physiology , Actins/drug effects , Actins/metabolism , Adrenergic beta-Antagonists/pharmacology , Animals , Antihypertensive Agents/pharmacology , Atenolol/pharmacology , Benzimidazoles/pharmacology , Biomarkers/blood , Biphenyl Compounds , Blood Pressure/drug effects , Collagen Type III/drug effects , Collagen Type III/metabolism , Creatinine/blood , Disease Models, Animal , Male , Models, Cardiovascular , Muscle, Smooth, Vascular/metabolism , Rats , Rats, Inbred SHR , Rats, Inbred WKY , Systole/drug effects , Systole/physiology , Tetrazoles/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL